Biomea Fusion to Participate at Upcoming Investor Conferences

Rhea-AI Summary

Biomea Fusion (Nasdaq: BMEA) will participate in three investor conferences in Feb–Mar 2026. Presentations and investor meetings are scheduled at Oppenheimer (virtual) on Feb 26, 2026 at 10:00 AM EDT, Citizens (Miami) on Mar 10, 2026 at 2:50 PM EDT, and BMO Metabolic Health Summit (panel) on Mar 24, 2026 at 11:00 AM EDT.

An audio webcast and replay will be available via the company’s News & Events page under Investors & Media.

SAN CARLOS, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or “Company” or “Company management”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that it will participate in the following upcoming investor conferences:

• Oppenheimer 36th Annual Healthcare Life Sciences Conference: Biomea will present virtually on February 26, 2026, at 10:00 AM (EDT). Company management will also meet with investors in one-on-one meetings during the conference.
  
  
• The Citizens Life Sciences Conference: Biomea will present at 2:50 PM (EDT) on March 10, 2026, in Miami, FL. Company management will also meet with investors in one-on-one meetings during the conference.
  
  
• BMO Metabolic Health Summit: Biomea will participate in a panel discussion on emerging competitors in the obesity and metabolic space on March 24, 2026, at 11:00 AM (EDT). Company management will also meet with investors in one-on-one meetings during the conference.
  

An audio webcast of the presentations will be available here or by visiting the News & Events page under the Investors & Media section of Biomea’s website. A replay of the webcasts will be available following each live event.

About Biomea Fusion  
Biomea Fusion is a clinical-stage biopharmaceutical company advancing oral small molecule therapies, icovamenib and BMF-650, for diabetes and obesity. These programs target metabolic disorders, a global health challenge affecting nearly half of Americans and one-fifth of the world’s population. Biomea’s mission is to deliver transformative treatments that restore health for patients living with diabetes, obesity, and related conditions. We aim to cure. 

Visit us at biomeafusion.com and follow us on LinkedIn, X and Facebook.  

Contact: 
Meichiel Jennifer Weiss
Sr. Director of Investor Relations and Corporate Development
ir@biomeafusion.com

FAQ

When will Biomea Fusion (BMEA) present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference?

Biomea Fusion will present virtually on February 26, 2026 at 10:00 AM EDT. According to Biomea, management will present and hold one-on-one investor meetings during the conference, and an audio webcast plus replay will be accessible via the company website.

What time is Biomea Fusion (BMEA) scheduled to present at the Citizens Life Sciences Conference on March 10, 2026?

Biomea Fusion is scheduled to present at 2:50 PM EDT on March 10, 2026 in Miami. According to Biomea, management will also hold one-on-one investor meetings and an audio webcast/replay will be available on its Investors & Media News & Events page.

Will Biomea Fusion (BMEA) participate in a panel at the BMO Metabolic Health Summit on March 24, 2026?

Yes. Biomea will join a panel discussion on emerging competitors in the obesity and metabolic space at 11:00 AM EDT on March 24, 2026. According to Biomea, management will also meet investors and provide an audio webcast with replay availability.

How can investors access Biomea Fusion (BMEA) webcasts and replays from the Feb–Mar 2026 conferences?

Investors can access audio webcasts and replays via the company’s News & Events page under Investors & Media. According to Biomea, live audio webcasts will be available from each presentation and replays posted after each live event.

Will Biomea Fusion (BMEA) hold one-on-one investor meetings at the upcoming conferences in 2026?

Yes. Biomea management will hold one-on-one investor meetings during each named conference. According to Biomea, these meetings accompany the virtual presentation on Feb 26, the March 10 presentation in Miami, and the March 24 panel participation.

Which topics will Biomea Fusion (BMEA) discuss at the BMO Metabolic Health Summit panel on March 24, 2026?

Biomea will participate in a panel on emerging competitors in the obesity and metabolic space. According to Biomea, the discussion will focus on competitive dynamics and related developments; an audio webcast and replay will be posted on the company website.